Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025
Mesa Laboratories (NASDAQ:MLAB), a global leader in life science tools and quality control solutions, has scheduled its first quarter fiscal year 2026 financial results announcement for August 5, 2025, at 8:00 A.M. Eastern time.
The company specializes in designing and manufacturing critical quality control solutions for regulated applications across pharmaceutical, healthcare, and medical device industries, focusing on product integrity, patient safety, and worker safety.
Mesa Laboratories (NASDAQ:MLAB), leader mondiale negli strumenti per le scienze della vita e nelle soluzioni di controllo qualità, ha programmato l'annuncio dei risultati finanziari del primo trimestre dell'anno fiscale 2026 per il 5 agosto 2025, alle 8:00 A.M. ora Eastern.
L'azienda è specializzata nella progettazione e produzione di soluzioni critiche di controllo qualità per applicazioni regolamentate nei settori farmaceutico, sanitario e dei dispositivi medici, con un focus sull'integrità del prodotto, la sicurezza del paziente e la sicurezza dei lavoratori.
Mesa Laboratories (NASDAQ:MLAB), líder mundial en herramientas para ciencias de la vida y soluciones de control de calidad, ha programado el anuncio de sus resultados financieros del primer trimestre del año fiscal 2026 para el 5 de agosto de 2025, a las 8:00 A.M. hora del Este.
La compañía se especializa en diseñar y fabricar soluciones críticas de control de calidad para aplicaciones reguladas en las industrias farmacéutica, sanitaria y de dispositivos médicos, enfocándose en la integridad del producto, la seguridad del paciente y la seguridad laboral.
Mesa Laboratories (NASDAQ:MLAB)는 생명 과학 도구 및 품질 관리 솔루션 분야의 글로벌 선도 기업으로, 2026 회계연도 1분기 재무 결과 발표를 2025년 8월 5일 오전 8시(동부 표준시)에 예정하고 있습니다.
이 회사는 제약, 의료 및 의료기기 산업의 규제된 응용 분야를 위한 핵심 품질 관리 솔루션을 설계하고 제조하는 데 특화되어 있으며, 제품 무결성, 환자 안전 및 근로자 안전에 중점을 두고 있습니다.
Mesa Laboratories (NASDAQ:MLAB), leader mondial des outils pour les sciences de la vie et des solutions de contrôle qualité, a programmé l'annonce de ses résultats financiers du premier trimestre de l'exercice 2026 pour le 5 août 2025 à 8h00, heure de l'Est.
L'entreprise se spécialise dans la conception et la fabrication de solutions de contrôle qualité essentielles pour des applications réglementées dans les industries pharmaceutique, des soins de santé et des dispositifs médicaux, en mettant l'accent sur l'intégrité des produits, la sécurité des patients et la sécurité des travailleurs.
Mesa Laboratories (NASDAQ:MLAB), ein weltweit führendes Unternehmen für Life-Science-Werkzeuge und Qualitätskontrolllösungen, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal des Geschäftsjahres 2026 für den 5. August 2025 um 8:00 Uhr Eastern Time geplant.
Das Unternehmen ist auf die Entwicklung und Herstellung kritischer Qualitätskontrolllösungen für regulierte Anwendungen in den Bereichen Pharmazie, Gesundheitswesen und Medizintechnik spezialisiert und legt dabei den Fokus auf Produktintegrität, Patientensicherheit und Arbeitsschutz.
- None.
- None.
LAKEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern time on Tuesday, August 5, 2025.
About Mesa Laboratories, Inc.
Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.
CONTACT: Gary Owens, President and CEO, or John Sakys, CFO, both of Mesa Laboratories, Inc., +1-303-987-8000
For more information about the Mesa, please visit our website at www.mesalabs.com.
FAQ
When will Mesa Laboratories (MLAB) release Q1 2026 earnings?
What industries does Mesa Laboratories (MLAB) serve?
How can investors access Mesa Laboratories' Q1 2026 earnings release?
Who are the key contacts for Mesa Laboratories investors?
